InflaRx (IFRX) Free Cash Flow (2016 - 2026)

InflaRx has disclosed Free Cash Flow across 11 years of filings, most recently posting -$8.6 million for Q1 2026.

• Free Cash Flow for Q1 2026 came in at -$8.6 million, up 41.33% year-over-year; the trailing twelve-month figure through Mar 2026 was -$33.4 million (up 34.77% YoY), and the FY2025 annual result was -$41.2 million, up 20.59% from the prior year.
• Free Cash Flow came in at -$8.6 million for Q1 2026 at InflaRx, down from -$5.7 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of -$3.2 million in Q3 2022 to a low of -$16.1 million in Q1 2024.
• The 5-year median for Free Cash Flow is -$11.3 million (2023), against an average of -$10.5 million.
• Across the five-year window, Free Cash Flow surged 72.88% in 2022 and sank 128.74% in 2023, its largest moves.
• InflaRx's Free Cash Flow stood at -$5.2 million in 2022, then tumbled by 128.74% to -$11.8 million in 2023, then slipped by 8.07% to -$12.8 million in 2024, then soared by 55.1% to -$5.7 million in 2025, then slumped by 50.47% to -$8.6 million in 2026.
• The last three Free Cash Flow figures came in at -$8.6 million (Q1 2026), -$5.7 million (Q4 2025), and -$10.5 million (Q3 2025), per Business Quant data.